Innovative Historical Cash Flow
| 002173 Stock | 8.93 0.55 6.56% |
Analysis of Innovative Medical cash flow over time is an excellent tool to project Innovative Medical future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Dividends Paid of 1.4 M or Other Cashflows From Investing Activities of 21.2 M as it is a great indicator of Innovative Medical ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Innovative Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Innovative Medical is a good buy for the upcoming year.
Innovative |
About Innovative Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Innovative balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Innovative's non-liquid assets can be easily converted into cash.
Innovative Medical Cash Flow Chart
Add Fundamental
Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Innovative Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Innovative Medical current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Innovative Medical Management. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Innovative Medical's Other Cashflows From Investing Activities is projected to increase significantly based on the last few years of reporting. The current year's Change To Inventory is expected to grow to about 7.2 M, whereas Capital Expenditures is forecasted to decline to about 84.7 M.
Innovative Medical cash flow statement Correlations
Click cells to compare fundamentals
Innovative Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Innovative Medical cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Capital Expenditures | 160.5M | 108.4M | 110.7M | 123.2M | 96.2M | 84.7M | |
| Net Income | (1.1B) | (314.5M) | (105.2M) | (73.7M) | (34.3M) | (36.0M) | |
| Other Cashflows From Financing Activities | (60.7M) | (36.8M) | 2.1M | (79.1M) | (71.2M) | (67.6M) | |
| Dividends Paid | 11.9M | 3.7M | 2.4M | 795.0K | 1.5M | 1.4M | |
| Total Cash From Financing Activities | (314.5M) | (63.5M) | (111.4M) | (3.0M) | (2.7M) | (2.5M) | |
| Other Cashflows From Investing Activities | 14.7M | 18.8M | 13.6M | 17.6M | 20.2M | 21.2M | |
| Change To Account Receivables | (48.3M) | 61.3M | 60.0M | 11.7M | 13.4M | 11.0M | |
| Total Cash From Operating Activities | 96.4M | 131.7M | 43.4M | (24.4M) | 11.0M | 10.5M | |
| Change To Inventory | (4.8M) | 17.2M | (8.0M) | (6.7M) | 6.8M | 7.2M | |
| Investments | 586M | (541M) | 5M | 460.0M | (415.3M) | (394.6M) | |
| Change In Cash | 306.5M | (533.1M) | (120.4M) | 432.6M | (409.3M) | (388.8M) | |
| Net Borrowings | (265.8M) | (61.9M) | (30M) | 11M | 12.7M | 13.3M | |
| Total Cashflows From Investing Activities | (120.5M) | 524.6M | (601.3M) | (52.4M) | (60.2M) | (63.3M) | |
| Depreciation | 104.4M | 111.8M | 117.5M | 110.3M | 106.7M | 101.5M | |
| Change To Operating Activities | 36.3K | 69.3M | 50.6M | 16.5M | 19.0M | 21.0M | |
| Change To Netincome | 139.7M | 988.6M | 138.1M | (14.4M) | (16.6M) | (15.8M) | |
| Change To Liabilities | 19.6M | 60.8M | 15.2M | (18.1M) | (16.3M) | (15.4M) | |
| End Period Cash Flow | 879.3M | 346.1M | 225.7M | 658.3M | 249.0M | 482.6M | |
| Free Cash Flow | (64.1M) | 23.3M | (67.4M) | (147.6M) | (85.2M) | (89.5M) | |
| Change In Working Capital | 94.2M | 116.6M | 18.9M | 9.8M | (43.0M) | (40.9M) | |
| Begin Period Cash Flow | 572.8M | 879.3M | 346.1M | 225.7M | 658.3M | 523.1M | |
| Other Non Cash Items | 27.0M | 14.4M | 9.5M | 12.8M | 10.0M | 16.6M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Innovative Stock
The Cash Flow Statement is a financial statement that shows how changes in Innovative balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Innovative's non-liquid assets can be easily converted into cash.